Last checked at LONDON MARKET MIDDAY: UK Banks Fall After Barclays Posts Profit Drop
LONDON MARKET MIDDAY: UK Banks Fall After Barclays Posts Profit Drop
18 Feb 21 12:12
- Home
- Share Prices
- AQSE Share Prices
- Share Chat
- FX
- News
- Blogs
- RNS
- Media
- Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News2
GSK Share
Chat41
GSK Share
Trades14,885
GSK
Live RNS1
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals2
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
GSK Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,208.80
Bid:
1,210.40
Ask:
1,211.00
Change:
8.20
(0.68%)
Spread:
0.60 (0.05%)
Open:
1,201.00
High:
1,221.40
Low:
1,198.60
Yest. Close:
1,200.60
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.18 Feb 21 12:12LONDON MARKET OPEN: Smith & Nephew Sinks After Covid-19 Hits Earnings
LONDON MARKET OPEN: Smith & Nephew Sinks After Covid-19 Hits Earnings
18 Feb 21 08:51GlaxoSmithKline Sets New Gender And Diversity Targets For 2025
GlaxoSmithKline Sets New Gender And Diversity Targets For 2025
17 Feb 21 19:14TOP NEWS: GSK, Vir Expand Deal To Include New Influenza Therapies
TOP NEWS: GSK, Vir Expand Deal To Include New Influenza Therapies
17 Feb 21 12:17GSK, Vir to collaborate on new therapeutics for influenza
(Sharecast News) - GlaxoSmithKline and Vir Biotechnology will expand their existing collaboration to include the research and development of new therapies for influenza and other respiratory viruses.
17 Feb 21 12:02GSK Starts Respiratory Syncytial Virus Candidate Vaccine Programme
GSK Starts Respiratory Syncytial Virus Candidate Vaccine Programme
16 Feb 21 09:55Moody's Affirms GSK's A2 Senior Unsecured Ratings; Outlook Negative
Moody's Affirms GSK's A2 Senior Unsecured Ratings; Outlook Negative
16 Feb 21 06:5015.3 million Britons receive first coronavirus vaccine dose
LONDON, Feb 15 (Reuters) - A total of 15,300,151 Britons have received the first dose of a COVID-19 jab, according to official data released on Monday, as the government begins to widen its vaccination programme to new groups of people.Britain als...
15 Feb 21 16:00Sanofi Covid-19 vaccines may be ready by end of 2021
(Sharecast News) - French drug giant Sanofi's two vaccine candidates against Covid-19 may be ready by year-end, the company said, refuting an earlier report.
15 Feb 21 12:17More than 14 million Britons have received first COVID-19 vaccine dose
LONDON, Feb 12 (Reuters) - A total of 14,012,224 Britons have received the first dose of a COVID-19 vaccine, official data showed on Friday, as the government races to vaccinate the most vulnerable people.Britain on Friday also reported 758 deaths...
12 Feb 21 16:01BROKER RATINGS: Exane Raises M&S; HSBC Ups Diploma To Buy
BROKER RATINGS: Exane Raises M&S; HSBC Ups Diploma To Buy
12 Feb 21 09:33UK Dividends Calendar - Next 7 Days
UK Dividends Calendar - Next 7 Days
11 Feb 21 16:09UPDATE 1-Novartis buys antibiotics business from GSK in generics push
(Writes through with details from GSK)ZURICH, Feb 11 (Reuters) - Swiss drugmaker Novartis' generics division is buying a GlaxoSmithKline antibiotics business that includes the brands Zinnat, Zinacef and Fortum for up to $500 million, the drugmaker...
11 Feb 21 15:54Novartis's Sandoz To Bolster Antibiotics With GSK Cephalosporin Buy
Novartis's Sandoz To Bolster Antibiotics With GSK Cephalosporin Buy
11 Feb 21 14:24Thursday broker round-up
(Sharecast News) - JD Wetherspoons: Peel Hunt downgrades to reduce with a target price of 1,150p.
11 Feb 21 14:18